René Beaudoin is appointed to HALEO's Board of Directors

Published on: March 9, 2022 | Reading time: 🕐 1m

HALEO | René Beaudoin is appointed to HALEO's Board of Directors
1:57

Montreal, QC, March 9th, 2022 – HALEO announced the appointment of Mr. René Beaudoin to its Board of Directors.  Mr. Beaudoin, a long-time executive in the corporate health and wellness industry, was appointed Executive Vice President, US Region and Chief Technology Officer of Morneau Shepell in 2011, serving in that role until 2016. He then joined Mercer, serving as Global Chief Operating Officer from 2017 until 2019.  In 2021 he was appointed Chief Executive Officer of Presagia, which was recently acquired by AbsenceSoft. Mr. Beaudoin is currently chair of the board of Amref Health Africa in Canada.

“René brings a wealth of experience and expertise in the human capital industry to HALEO”, said Julien Ponce, HALEO’s chairman of the board. “We are honored to have him join our Board of Directors, and we look forward to benefiting from his insight and other contributions as we continue to expand HALEO across North America."

Mr. Beaudoin commented that “HALEO’s corporate sleep solution is unique and innovative, and it solves a problem that’s costing organizations billions each year. I am excited to be able to contribute to HALEO’s strategic planning and development as we aim to help organizations reduce the impact of poor sleep on their people and on their bottom line.”

About HALEO

Founded in 2015, HALEO is an online sleep clinic whose mission is to provide access to quality care based on clinically proven solutions for those suffering from insomnia or other sleep disorders. Its clinical experts provide personalized professional treatments supported by clinical research and accessible via a mobile application.  The services offered, ranging from screening to the management of sleep disorders, have already helped improve the health and performance of thousands of people across Canada and the US by helping them overcome their sleep problems.  

For more information: Media@haleoclinic.com

M128 - More News